glp-1 colorectal cancer mortality study november 2025 receptor agonists—the class of drugs behind Ozempic, Wegovy, and Mounjaro—may do more than regulate blood sugar and weight. In an analysis of more than 6,800 colon patients across GLP-1 receptor agonists show anti-cancer
Description
Not to reject progress, but to claim ownership of its risks
Virta ships a starter kit at enrollment containing a connected scale, meter, recipes, and guides
The risk may be greater for those using the drugs at higher doses or for longer stretches of time
Plaintiffs allege the drug labels failed to disclose the risk of NAION or other severe vision complications, depriving patients of the ability to make informed treatment decisions
Diabetes - laying of the first stepping stone The GLP-1 journey is rooted in the long search to understand diabetes, a condition first recognised as a medical problem in Ancient Egypt
Nausea after a GLP-1 injection can typically start within the first 24-48 hours after the first dose or shortly after an increased dose
